|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.50 GBX | 0.00% |
|
-2.42% | +3.79% |
| 06-30 | EARNINGS AND TRADING: Made Tech forecast revenue ahead of forecast | AN |
| 06-04 | Venture Life buys two US healthcare brands for USD28 million | AN |
| Market Cap | 83.45M 113M 97.7M 91.46M 157M 10.75B 160M 1.07B 420M 5.38B 423M 414M 17.96B | P/E 2026 * |
-29.8x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 48.75M 65.86M 57.07M 53.43M 91.74M 6.28B 93.28M 627M 245M 3.14B 247M 242M 10.49B | EV / Sales 2026 * |
0.97x | EV / Sales 2027 * | 1.16x |
| Free-Float |
82.81% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Venture Life Group plc
| 25-08-05 | Venture Life : Result of General Meeting | PU |
| 25-07-16 | Venture Life : Notice of General Meeting | PU |
| 25-06-30 | Venture Life : 2025 AGM Results | PU |
| 25-06-06 | Venture Life : 2025 Notice of AGM | PU |
| 24-06-04 | Venture Life : 2024 AGM Results | PU |
| 1 week | -2.42% | ||
| Current month | -1.72% | ||
| 1 month | +3.01% | ||
| 3 months | +22.32% | ||
| 6 months | -3.52% | ||
| Current year | +3.79% |
| 1 week | 68 |  | 70 |
| 1 month | 66 | | 71 |
| Current year | 54 | | 72 |
| 1 year | 52 | | 72 |
| 3 years | 27 | | 72 |
| 5 years | 23 | | 95 |
| 10 years | 20 | | 118 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeremy Randall
CEO | Chief Executive Officer | 62 | 2010-02-28 |
Daniel Wells
DFI | Director of Finance/CFO | 39 | 2021-11-30 |
Peter Jackson
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Randall
BRD | Director/Board Member | 62 | 2005-12-11 |
Carl Dempsey
BRD | Director/Board Member | - | 2018-09-19 |
Daniel Wells
BRD | Director/Board Member | 39 | 2021-12-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/12/26 | Buy | 2,959 | 0.0024% | |||
| 1/9/26 | Sell | Founder | 10,000 | 0.0079% | ||
| 1/9/26 | Sell | Founder | 173,015 | 0.1366% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.42% | +10.93% | +119.20% | 113M | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,083B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 626B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 442B | |
| -1.13% | +3.13% | +49.78% | +39.13% | 363B | |
| -0.74% | +1.01% | +31.08% | +38.64% | 295B | |
| -1.22% | +0.89% | +7.32% | +7.38% | 248B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 224B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 210B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 168B | |
| Average | -0.27% | +1,503.45% | +31.90% | +52.52% | 365.92B | |
| Weighted average by Cap. | -0.62% | +1,332.58% | +49.63% | +66.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.35M 68.02M 58.95M 55.18M 94.75M 6.49B 96.35M 647M 254M 3.25B 255M 250M 10.83B | 54.7M 73.89M 64.04M 59.95M 103M 7.05B 105M 703M 275M 3.53B 277M 271M 11.77B |
| Net income | -3.21M -4.34M -3.76M -3.52M -6.05M -414M -6.15M -41.29M -16.18M -207M -16.3M -15.94M -691M | 5.3M 7.15M 6.2M 5.8M 9.96M 682M 10.13M 68.04M 26.66M 341M 26.86M 26.27M 1.14B |
| Net Debt | -34.7M -46.88M -40.62M -38.03M -65.3M -4.47B -66.4M -446M -175M -2.24B -176M -172M -7.47B | -20.2M -27.29M -23.65M -22.14M -38.01M -2.6B -38.65M -260M -102M -1.3B -102M -100M -4.35B |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | GBX 68.50 | 0.00% | 31,908 |
| 26-08-10 | GBX 68.50 | -0.44% | 193,505 |
| 26-08-07 | GBX 68.80 | 0.00% | 37,070 |
| 26-08-06 | GBX 68.80 | -1.29% | 45,981 |
| 26-08-05 | GBX 69.70 | -0.71% | 201,511 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6850GBP
Average target price
1.500GBP
Spread / Average Target
+118.98%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VLG Stock
Select your edition
All financial news and data tailored to specific country editions
